Prevalence of Pol d 1 Sensitization in Polistes dominula Allergy and Its Diagnostic Role in Vespid Double-Positivity.

CAP-inhibition Cross-reactivity Double-sensitization Hymenoptera allergy Phospholipase A1 Pol d 1 Pol d 5 Polistes Venom immunotherapy Vespid

Journal

The journal of allergy and clinical immunology. In practice
ISSN: 2213-2201
Titre abrégé: J Allergy Clin Immunol Pract
Pays: United States
ID NLM: 101597220

Informations de publication

Date de publication:
10 2021
Historique:
received: 03 04 2021
revised: 22 05 2021
accepted: 25 05 2021
pubmed: 20 6 2021
medline: 29 10 2021
entrez: 19 6 2021
Statut: ppublish

Résumé

Stings by Polistes species frequently cause allergic reactions. However, standard allergy diagnostics are often unable to differentiate between primary sensitization and cross-reactivity in case of Vespula/Polistes double-sensitization because antigen 5 is the only Polistes venom molecule currently available in diagnostics (Pol d 5). To evaluate the frequency of phospholipase A1 in Polistes venom allergy (Pol d 1) and its diagnostic role in vespid allergy. We performed component-resolved diagnostics in patients with vespid allergic reactions who were positive to Polistes venom. A prevalence analysis was performed and the diagnostic accuracy of Pol d 1 was evaluated to detect primary Polistes sensitization in double-sensitized patients. Blood samples were collected from 132 patients. Pol d 1 was present in 97% to 100% of 128 Polistes-positive patients. It was frequently involved in case of positivity to a single Polistes molecule (48% in double- and 80% in mono-sensitized patients). Furthermore, Pol d 1 was positive in 95% of Pol d 5-negative subjects. The diagnostic accuracy of Pol d 1 was good (folded type: area under the curve = 87%; 82% sensitivity and 77% specificity at the best cutoff of 5.773), and even better when used combined with the whole extract ratio (area under the curve = 99%; 91% sensitivity and 100% specificity). The study shows that Pol d 1 is the most frequent Polistes allergen in Italian patients. It can distinguish Polistes primary sensitizations with good diagnostic accuracy, which supports its use in clinical practice.

Sections du résumé

BACKGROUND
Stings by Polistes species frequently cause allergic reactions. However, standard allergy diagnostics are often unable to differentiate between primary sensitization and cross-reactivity in case of Vespula/Polistes double-sensitization because antigen 5 is the only Polistes venom molecule currently available in diagnostics (Pol d 5).
OBJECTIVE
To evaluate the frequency of phospholipase A1 in Polistes venom allergy (Pol d 1) and its diagnostic role in vespid allergy.
METHODS
We performed component-resolved diagnostics in patients with vespid allergic reactions who were positive to Polistes venom. A prevalence analysis was performed and the diagnostic accuracy of Pol d 1 was evaluated to detect primary Polistes sensitization in double-sensitized patients.
RESULTS
Blood samples were collected from 132 patients. Pol d 1 was present in 97% to 100% of 128 Polistes-positive patients. It was frequently involved in case of positivity to a single Polistes molecule (48% in double- and 80% in mono-sensitized patients). Furthermore, Pol d 1 was positive in 95% of Pol d 5-negative subjects. The diagnostic accuracy of Pol d 1 was good (folded type: area under the curve = 87%; 82% sensitivity and 77% specificity at the best cutoff of 5.773), and even better when used combined with the whole extract ratio (area under the curve = 99%; 91% sensitivity and 100% specificity).
CONCLUSIONS
The study shows that Pol d 1 is the most frequent Polistes allergen in Italian patients. It can distinguish Polistes primary sensitizations with good diagnostic accuracy, which supports its use in clinical practice.

Identifiants

pubmed: 34146747
pii: S2213-2198(21)00660-7
doi: 10.1016/j.jaip.2021.05.033
pii:
doi:

Substances chimiques

Allergens 0
Wasp Venoms 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3781-3787

Informations de copyright

Copyright © 2021. Published by Elsevier Inc.

Auteurs

Maria Beatrice Bilò (MB)

Department of Clinical and Molecular Sciences, Universita' Politecnica delle Marche, Ancona, Italy; Allergy Unit, Department of Internal Medicine, Azienda Ospedaliero-Universitaria Ospedali Riuniti, Ancona, Italy. Electronic address: m.b.bilo@univpm.it.

Matteo Martini (M)

Global Clinical Development, Chiesi Farmaceutici S.p.A., Parma, Italy.

Patrizia Bonadonna (P)

Allergy Unit, Policlinico G.B. Rossi, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.

Barbara Cinti (B)

Laboratory Medicine, Ospedaliero-Universitaria Ospedali Riuniti, Ancona, Italy.

Mirella Da Re (M)

Immunology and Allergy Unit, Santa Maria degli Angeli Hospital, Pordenone, Italy.

Oretta Gabrielli (O)

Immunology Unit, Policlinico G.B. Rossi, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.

Francesco Olivieri (F)

Allergy Unit, Policlinico G.B. Rossi, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.

Valeria Salgarolo (V)

Immunology and Allergy Unit, Santa Maria degli Angeli Hospital, Pordenone, Italy.

Giovanna Zanoni (G)

Immunology Unit, Policlinico G.B. Rossi, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.

Danilo Villalta (D)

Immunology and Allergy Unit, Santa Maria degli Angeli Hospital, Pordenone, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH